The Global market for Tissue diagnostics is poised to reach million by the end of 2020 growing at a CAGR of. Tissue based diagnostics serves as one of the most important technique for cancer diagnosis. There is no other technology that can capture the disease insights and the parameters that factor into the patient outcomes. Tissue diagnostic aka Histopathology is the study of disease in tissue. Samples usually consist of pieces of tissue in various obtained by various methods. These include small biopsies, large specimens removed at surgery. Tissues generally enable personalized diagnosis & treatment.
Tissue tests will spearhead the IVD industry revenue in the future.Currently, North America is the largest market in the world followed by Europe. This can be attributed to the increased awareness about the potential benefits of diagnostics among the population. APAC is the fastest growing segment.
The Tissue diagnostic market can be segmented on the basis of Technology (H&E slide staining, IHC, ISH, Special Stains & Digital Pathology), Platform (High Throughput Scanning, H&E Staining, Image management, IHC/ISH staining, special stains, Brightfield Scanning), Application (Prostate cancer, lung cancer, breast cancer, colorectal cancer, skin cancer, cervical cancer, lymphoma and gastric cancer), Product (Instruments, reagents), End User (CRO, Research labs, hospitals, pharmaceuticals) and Geography (North America, Europe, APAC & RoW).DriversGrowth of personalized medicine, upsurge of cancer patients, increasing opportunities in digital pathology and high demand for companion & molecular diagnostics are the major factors driving the growth of the market.RestraintsLimited customer base for tissue diagnostics, limited budget issues and regulatory framework issues are the factors hindering the growth of the market.
What the report offers
1* Market Definition for the specified topic along with identification of key drivers and restraints for the market.
2* Market analysis for the Global Tissue Diagnostics Market, with region specific assessments and competition analysis on a global and regional scale.
3* Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4* Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
5* Identification and analysis of the Macro and Micro factors that affect the Global Tissue Diagnostics market on both global and regional scale.
6* A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.